Toutes les photos(1)

Principaux documents

COO/COA

Voir toute la documentation

484628

Benztropine mesylate

Name: Benztropine mesylate
Brand: ALDRICH

95%

Synonyme(s) :

Benztropine methanesulfonate

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):

C₂₁H₂₅NO

Numéro CAS:

132-17-2

Poids moléculaire :

307.43

Numéro CE :

205-048-8

Numéro MDL:

MFCD00074784

Code UNSPSC :

12352103

Pureté

95%

Pf

135 °C (lit.)

Chaîne SMILES

CS(O)(=O)=O.CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(c3ccccc3)c4ccccc4

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Pictogrammes

GHS06

Mention d'avertissement

Danger

Mentions de danger

H302,H311 + H331

Conseils de prudence

P261 - P264 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P311

Classification des risques

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 4 Oral

Code de la classe de stockage

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Équipement de protection individuelle

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

20511TR

13802TR

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.

Clara Velázquez-Sánchez et al.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 34(12), 2497-2507 (2009-07-17)

Benztropine (BZT) analogs, a family of high-affinity dopamine transporter ligands, are molecules that exhibit pharmacological and behavioral characteristics predictive of significant therapeutic potential in cocaine addiction. Here, we examined in mice the effects of 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane (AHN-1055) on motor activity

N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects.

Su-Min Li et al.

The Journal of pharmacology and experimental therapeutics, 336(2), 575-585 (2010-11-23)

Previous studies suggested that differences between the behavioral effects of cocaine and analogs of benztropine were related to the relatively slow onset of action of the latter compounds. Several N-substituted benztropine analogs with a relatively fast onset of effects were

Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction.

Clara Velazquez-Sanchez et al.

The international journal of neuropsychopharmacology, 14(5), 655-665 (2010-08-26)

N-substituted benztropine (BZT) analogs are molecules that display high affinity for the dopamine transporter (DAT), therapeutic-like effects in animal models of cocaine abuse, and psychopharmacological characteristics consistent with those of a substitute medication for cocaine addiction. Since amphetamine (Amph) and

Interventions for drooling in children with cerebral palsy.

Margaret Walshe et al.

The Cochrane database of systematic reviews, 2(2), CD008624-CD008624 (2012-02-18)

Drooling is a common problem for children with cerebral palsy (CP). This can be distressing for these children as well as for their parents and caregivers. The consequences of drooling include risk of social rejection, damp and soiled clothing, unpleasant

A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.

Brooke E Schmeichel et al.

Neuropharmacology, 64, 321-328 (2012-07-17)

Drugs used to treat attention deficit hyperactivity disorder (ADHD) improve prefrontal cortex (PFC)-dependent cognitive function. The majority of ADHD-related treatments act either as dual norepinephrine (NE) and dopamine (DA) reuptake inhibitors (psychostimulants) or selective NE reuptake inhibitors (SNRIs). Certain benztropine

Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique